Clinical trial
Chemotherapy and Monoclonal Antibody Therapy in Treating Patients With B-cell…
NCT00003963 · Jonsson Comprehensive Cancer Center, Other · Completed
Key facts
| NCT number | NCT00003963 |
|---|---|
| Title | Chemotherapy and Monoclonal Antibody Therapy in Treating Patients With B-cell Non-Hodgkin's Lymphoma That Has Relapsed Following Peripheral Stem Cell Transplantation |
| Official title | Treatment of B-Cell NHL Relapsing After Transplant With a Rituxan Vinorelbine Combination |
| Lead sponsor | Jonsson Comprehensive Cancer Center, Other |
| Collaborators | National Cancer Institute (NCI) NIH Genentech, Inc. Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Lymphoma |
| Intervention type | Biological, Drug |
| Interventions | rituximab, vinorelbine ditartrate |
| Enrollment | 14 |
| Start date | May 1, 1999 |
| Primary completion | Sep 1, 2003 |
| Completion | Feb 1, 2005 |
| First posted | Jan 27, 2003 |
| Last update posted | Aug 3, 2020 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: